Epilepsy Therapeutic Market in APAC 2020-2024

Global Epilepsy therapeutic market in APAC 2020-2024

Technavio has been monitoring the epilepsy therapeutic market in APAC and it is poised to grow by $ 232.12 mn during 2020-2024 progressing at a CAGR of 3% during the forecast period. Our reports on epilepsy therapeutic market in APAC provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current APAC market scenario, latest trends and drivers, and the overall market environment. The market is driven by the high unmet medical need, increase in patient population and rising awareness. In addition, high unmet medical need is anticipated to boost the growth of the market as well.

The epilepsy therapeutic market in APAC analysis includes product segments.1.

Technavio's epilepsy therapeutic market in APAC is segmented as below:

By Product

  • First-generation epilepsy therapeutics
  • Second-generation epilepsy therapeutics
  • Third-generation epilepsy therapeutics
By Geographic Landscapes
  • Asia
  • Rest of APAC
This study identifies the emergence of new-generation AEDs as one of the prime reasons driving the epilepsy therapeutic market in APAC growth during the next few years. Also, reformulation of marketed drugs and AEDs with novel mechanism of action will lead to sizable demand in the market.

"Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our epilepsy therapeutic market in APAC covers the following areas:
  • Epilepsy therapeutic market in APAC sizing
  • Epilepsy therapeutic market in APAC forecast
  • Epilepsy therapeutic market in APAC industry analysis"
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading epilepsy therapeutic market in APAC vendors that include Bausch Health Companies Inc., BIAL - PORTELA & CA SA, GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Pfizer Inc., Sanofi, Sunovion Pharmaceuticals Inc., UCB SA, and Zogenix Inc.. Also, the epilepsy therapeutic market in APAC analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.


  • Executive Summary
  • Market Landscape
    • Market ecosystem
      • Table Parent market
    • Market characteristics
      • Table Market characteristics
    • Value chain analysis
      • Table Value chain analysis - Pharmaceuticals
      • Research and development (R&D) and drug discovery:
      • Integration and product development:
      • Manufacturing:
      • Outbound logistics:
      • Marketing and sales:
      • Support services:
  • Market Sizing
    • Market definition
      • Table Offerings of vendors included in the market definition
    • Market segment analysis
      • Table Market segments
    • Market size 2019
    • Market outlook: Forecast for 2019 - 2024
      • Table APAC - Market size and forecast 2019 - 2024 ($ million)
      • Table APAC - Market size and forecast 2019-2024 ($ million) exclusive of COVID-19 effect
      • Table Global market: Year-over-year growth 2019 - 2024 (%)
  • Five Forces Analysis
    • Five forces summary
      • Table Five forces analysis 2019 & 2024
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2019
  • Market Segmentation by Product
    • Market segments
      • Table Product - Market share 2019-2024 (%)
    • Comparison by Product
      • Table Comparison by Product
    • First-generation epilepsy therapeutics - Market size and forecast 2019-2024
      • Table First-generation epilepsy therapeutics - Market size and forecast 2019-2024 ($ million)
      • Table First-generation epilepsy therapeutics- Market size and forecast 2019-2024 ($ million) exclusive of COVID-19 effect
      • Table Approval scenario: First-generation epilepsy therapeutics
      • Table First-generation epilepsy therapeutics - Year-over-year growth 2019-2024 (%)
    • Second-generation epilepsy therapeutics - Market size and forecast 2019-2024
      • Table Second-generation epilepsy therapeutics - Market size and forecast 2019-2024 ($ million)
      • Table Second-generation epilepsy therapeutics - Market size and forecast 2019-2024 ($ billion) exclusive of COVID-19 effect
      • Table Second-generation epilepsy therapeutics - Year-over-year growth 2019-2024 (%)
    • Third-generation epilepsy therapeutics - Market size and forecast 2019-2024
      • Table Third-generation epilepsy therapeutics - Market size and forecast 2019-2024 ($ million)
      • Table Third-generation epilepsy therapeutics - Market size and forecast 2019-2024 ($ billion) exclusive of COVID-19 effect
      • Table Third-generation epilepsy therapeutics - Year-over-year growth 2019-2024 (%)
    • Market opportunity by Product
      • Table Market opportunity by Product
  • Customer Landscape
    • Table Customer landscape
  • Geographic Landscape
    • Geographic segmentation
      • Table Market share by geography 2019-2024 (%)
    • Geographic comparison
      • Table Geographic comparison
    • Asia - Market size and forecast 2019-2024
      • Table Asia - Market size and forecast 2019-2024 ($ million)
      • Table Asia - Market size and forecast 2019-2024 ($ million) exclusive of COVID-19 effect
      • Table Asia - Year-over-year growth 2019-2024 (%)
    • Rest of APAC - Market size and forecast 2019- 2024
      • Table Rest of APAC - Market size and forecast 2019-2024 ($ million)
      • Table Rest of Asia - Market size and forecast 2019-2024 ($ million) exclusive of COVID-19 effect
      • Table Rest of APAC - Year-over-year growth 2019-2024 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity by geography
      • Table Market opportunity by geography ($ million)
  • Drivers, Challenges, and Trends
    • Market drivers
      • High unmet medical need
      • Increase in patient population
      • Rising awareness
    • Market challenges
      • Generic erosion
      • Technological advancements in non-invasive neuromodulation and seizure management devices
      • Social stigma associated with mental disorders
        • Table Impact of drivers and challenges
    • Market trends
      • Reformulation of marketed drugs
      • Emergence of new-generation AEDs
      • AEDs with novel mechanism of action
  • Vendor Landscape
    • Overview
    • Vendor landscape
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
      • Table Industry risks
  • Vendor Analysis
    • Vendors covered
      • Table Vendors covered
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Bausch Health Companies Inc.
      • Table Bausch Health Companies Inc. - Overview
      • Table Bausch Health Companies Inc. - Business segments
      • Table Bausch Health Companies Inc. - Key news
      • Table Bausch Health Companies Inc. - Key offerings
      • Table Bausch Health Companies Inc. - Segment focus
    • BIAL - PORTELA & CA SA
      • Table BIAL - PORTELA & CA SA - Overview
      • Table BIAL - PORTELA & CA SA - Product and service
      • Table BIAL - PORTELA & CA SA - Key news
      • Table BIAL - PORTELA & CA SA - Key offerings
    • GlaxoSmithKline Plc
      • Table GlaxoSmithKline Plc - Overview
      • Table GlaxoSmithKline Plc - Business segments
      • Table GlaxoSmithKline Plc - Key news
      • Table GlaxoSmithKline Plc - Key offerings
      • Table GlaxoSmithKline Plc - Segment focus
    • Johnson & Johnson
      • Table Johnson & Johnson - Overview
      • Table Johnson & Johnson - Business segments
      • Table Johnson & Johnson - Key news
      • Table Johnson & Johnson - Key offerings
      • Table Johnson & Johnson - Segment focus
    • Novartis AG
      • Table Novartis AG - Overview
      • Table Novartis AG - Business segments
      • Table Novartis AG. - Key news
      • Table Novartis AG - Key offerings
      • Table Novartis AG - Segment focus
    • Pfizer Inc.
      • Table Pfizer Inc. - Overview
      • Table Pfizer Inc. - Business segments
      • Table Pfizer Inc. - Key news
      • Table Pfizer Inc. - Key offerings
      • Table Pfizer Inc. - Segment focus
    • Sanofi
      • Table Sanofi - Overview
      • Table Sanofi - Business segments
      • Table Sanofi - Key news
      • Table Sanofi - Key offerings
      • Table Sanofi - Segment focus
    • Sunovion Pharmaceuticals Inc.
      • Table Sunovion Pharmaceuticals Inc. - Overview
      • Table Sunovion Pharmaceuticals Inc. - Product and service
      • Table Sunovion Pharmaceuticals Inc. - Key offerings
    • UCB SA
      • Table UCB SA - Overview
      • Table UCB SA - Product and service
      • Table UCB SA - Key news
      • Table UCB SA - Key offerings
    • Zogenix Inc.
      • Table Zogenix Inc. - Overview
      • Table Zogenix Inc. - Product and service
      • Table Zogenix Inc. - Key news
      • Table Zogenix Inc. - Key offerings
  • Appendix
    • Scope of the report
      • Scope
      • Objectives
      • Notes and caveats
    • Currency conversion rates for US$
      • Table Currency conversion rates for US$
    • Research methodology
      • Table Research Methodology
      • Table Validation techniques employed for market sizing
      • Table Information sources
    • List of abbreviations
      • Table List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook